Johnson & Johnson MedTech Executive and Leadership Team

Gigi Chang, the Chief Financial Officer, Medtech (Canada) at Johnson & Johnson MedTech, manages the fiscal health and capital allocation strategies for North American operations. Chang oversees financial planning, budgeting, and risk management to ensure sustainable growth within the Canadian market. By analyzing market trends and operational costs, the Chief Financial Officer provides actionable insights that guide strategic decision-making for medical device manufacturing. This leadership role involves collaborating with regional stakeholders to maximize profitability while maintaining high standards of product quality. Gigi Chang directs the financial reporting processes that support transparency and regulatory compliance. Through the optimization of resource distribution, the Chief Financial Officer strengthens the company's ability to invest in innovative healthcare solutions. Ultimately, Chang ensures long-term financial stability and operational efficiency for the organization across the region.

Jennifer Lu, the Vice President, Finance & Chief Financial Officer, Medtech (Asia Pacific) at Johnson & Johnson MedTech, directs the financial strategy and economic performance for operations across the Asia Pacific region. Lu oversees complex budgeting processes and investment analysis to support the expansion of medical technology services in emerging markets. By monitoring regional economic indicators, the Chief Financial Officer ensures that financial resources align with the company's strategic goals for healthcare innovation. This leadership role involves coordinating with global finance teams to maintain fiscal discipline and regulatory adherence. Jennifer Lu manages the financial risks associated with international trade and supply chain logistics. Through the implementation of rigorous financial controls, the Chief Financial Officer optimizes capital efficiency. Ultimately, Lu drives the financial health and market competitiveness of the organization throughout the Asia Pacific territory.

Sarah Najdek, the President, Surgery (Asia Pacific) at Johnson & Johnson MedTech, directs the commercial strategy and market penetration for surgical intervention products across the Asia Pacific region. Najdek oversees the deployment of advanced medical devices to hospitals and clinical facilities, ensuring that healthcare providers have access to cutting-edge technology. By analyzing regional surgical trends, the President develops tailored solutions that address specific clinical needs. This leadership role involves managing relationships with key medical stakeholders and driving the adoption of innovative surgical therapies. Sarah Najdek coordinates with regional sales and marketing teams to expand the company's footprint in high-growth markets. Through the execution of strategic growth plans, the President enhances the company's impact on patient care. Ultimately, Najdek ensures the successful delivery of surgical solutions that improve medical outcomes throughout the Asia Pacific region.

Sharrolyn Josse, the Global President Joint Reconstruction- Hips, Knees and Shoulders at Johnson & Johnson MedTech, directs the product development and commercial strategy for orthopedic medical devices. Josse oversees the manufacturing and distribution of advanced implants designed to restore mobility and improve patient quality of life. By analyzing orthopedic market demands, the Global President architects innovative solutions for joint replacement procedures. This leadership role involves managing global supply chains and ensuring that orthopedic products meet rigorous quality standards. Sharrolyn Josse coordinates with clinical experts to refine device design and enhance surgical outcomes. Through the implementation of strategic marketing initiatives, the Global President drives the adoption of orthopedic technologies in hospitals worldwide. Ultimately, Josse ensures that the company remains a leader in the joint reconstruction market by delivering high-performance medical devices that address the needs of patients and surgeons.

Edward Zhou, the President (China) at Johnson & Johnson MedTech, directs the overall business operations and strategic growth initiatives within the Chinese market. Zhou oversees the localization of medical technology solutions to meet the specific regulatory and clinical requirements of the region. By managing local partnerships and distribution networks, the President ensures the effective delivery of advanced healthcare devices to medical institutions. This leadership role involves navigating complex market dynamics and aligning regional activities with the company's global mission. Edward Zhou coordinates with cross-functional teams to drive sales performance and operational efficiency. Through the execution of market-specific strategies, the President expands the company's presence in the rapidly growing Chinese healthcare sector. Ultimately, Zhou secures the company's competitive position by fostering innovation and maintaining strong relationships with local healthcare providers and regulatory bodies.

Ryan Benishake, the Co-Distributor Principal and President of One Medtech East, Inc. at Johnson & Johnson MedTech, directs the distribution logistics and commercial operations for medical technology products in the eastern region. Benishake oversees the supply chain management and inventory control processes that ensure timely delivery of critical medical devices to healthcare facilities. By managing distributor relationships, the President optimizes the reach of the company's product portfolio. This leadership role involves implementing sales strategies that align with regional market demands and corporate objectives. Ryan Benishake coordinates with internal teams to ensure that distribution channels operate with maximum efficiency and compliance. Through the management of regional operations, the President supports the company's mission to provide accessible healthcare solutions. Ultimately, Benishake ensures the reliable availability of medical technology, directly impacting the ability of healthcare providers to perform essential interventions.

Prithvi Sahoo, the Chief Information Officer, Shockwave Medical at Johnson & Johnson MedTech, directs the digital infrastructure and data security protocols essential for advanced medical device manufacturing. Sahoo architects scalable cloud environments that support the integration of complex healthcare data across global networks. By overseeing the deployment of secure mobile platforms, the Chief Information Officer ensures seamless connectivity for clinical partners. This leadership role involves aligning technological investments with the broader mission of improving patient outcomes through precision engineering. Prithvi Sahoo maintains rigorous compliance standards while driving digital transformation initiatives that optimize internal workflows. Through the implementation of robust cybersecurity frameworks, the Chief Information Officer protects sensitive medical information. Ultimately, Sahoo secures the technological foundation required for the company to maintain a competitive edge in the rapidly evolving medical technology sector.

Sword Zheng, the Chief Human Resources Officer at Johnson & Johnson MedTech, architects the talent acquisition and organizational development strategies that drive the company's global workforce. Zheng oversees the cultivation of a high-performance culture focused on innovation and medical excellence. By implementing comprehensive training programs, the Chief Human Resources Officer ensures that the workforce possesses the specialized skills required for advanced healthcare manufacturing. This leadership role involves managing employee engagement initiatives and fostering diversity across international teams. Sword Zheng directs the design of compensation structures that attract top-tier talent in the competitive medical technology industry. Through the alignment of human capital with corporate objectives, the Chief Human Resources Officer supports the company's mission to transform medical intervention capabilities. Ultimately, Zheng builds the organizational capacity necessary to sustain long-term growth and operational success.

Yvan Francois, the Chief of Staff To the Executive Vice President and WW Chain JJMedTech at Johnson & Johnson MedTech, coordinates strategic initiatives and operational alignment across the global supply chain. Francois facilitates communication between executive leadership and functional departments to ensure the seamless execution of manufacturing objectives. By overseeing project timelines and resource allocation, the Chief of Staff ensures that the company meets the high demand for advanced medical devices. This leadership role involves analyzing operational data to identify bottlenecks and implement process improvements. Yvan Francois directs the integration of supply chain strategies with the company's broader mission of delivering purposeful healthcare technology. Through the management of cross-functional workflows, the Chief of Staff enhances organizational agility. Ultimately, Francois supports the Executive Vice President in maintaining operational excellence and meeting global market requirements.

Sanjeev Aggarwal, the Global Chief Medical Officer, Surgical Therapies Abiomed at Johnson & Johnson MedTech, directs the clinical strategy and medical research initiatives for advanced surgical therapies. Aggarwal oversees the evaluation of medical device efficacy and safety, ensuring that all products meet the highest standards of clinical performance. By collaborating with medical researchers and surgeons, the Global Chief Medical Officer drives the development of innovative interventions for complex cardiovascular conditions. This leadership role involves providing clinical guidance to product development teams to ensure that technology aligns with real-world medical requirements. Sanjeev Aggarwal manages the dissemination of clinical data to support the adoption of new surgical techniques. Through the oversight of clinical trials and medical education programs, the Global Chief Medical Officer advances the company's mission of transforming patient care. Ultimately, Aggarwal ensures the clinical integrity of all surgical therapy solutions.